Veradermics
MANE
110.95
+1.99
+1.83%
Veradermics
US · MANE
#2148 by market cap
Listed 2026
110.95
+1.99
+1.83%
Live - 5344 symbols - heartbeat 283s ago
· 2026-10-08 07:00
Pre-market
111.10
+0.14%
After-hours
110.95
0.00%
Overnight
110.95
0.00%
- Market cap
- 4.64B
- P/E (TTM)i
- -44.45
- P/Bi
- 5.70
- EPSi
- -2.23
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on MANE?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Analysts Are Bullish on Top NA Stocks: Veradermics, Incorporated (MANE), Bicara Therapeutics Inc. (BCAX)TipRanks · 2026/8/12
-
Rating change
Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $182Market Newswire · 2026/7/16
-
Rating change
Needham Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $164Market Newswire · 2026/8/13
-
Rating change
B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy RatingTipRanks · 2026/7/16
-
Rating change
Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $138Market Newswire · 2026/5/14
-
Rating change
LifeSci Capital Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $135Market Newswire · 2026/6/16
-
Rating change
Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $138Market Newswire · 2026/6/16
-
Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $160Market Newswire · 2026/9/15
-
Rating change
Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $182Market Newswire · 2026/7/7
-
Rating change
Analysts Conflicted on These NA Names: HeartFlow, Inc. (HTFL), Phoenix Education Partners, Inc. (PXED) and Veradermics, Incorporated (MANE)TipRanks · 2026/7/15
-
Rating change
Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $135Market Newswire · 2026/5/18
-
Veradermics(MANE.US) Officer Sells US$7.28 Million in Common StockMarket Newswire · 2026/8/19
-
LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $170Market Newswire · 2026/8/12
-
Rating change
Needham Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $136Market Newswire · 2026/6/2
-
LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $170Market Newswire · 2026/7/15
-
Veradermics(MANE.US) Officer Sells US$4.69 Million in Common StockMarket Newswire · 2026/8/19
-
Rating change
Needham Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $164Market Newswire · 2026/7/15
-
Rating change
Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $160Market Newswire · 2026/7/16
-
Rating change
Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $135Market Newswire · 2026/6/22
-
Rating change
B. Riley Securities Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $170Market Newswire · 2026/7/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:00:21 · For reference only, not investment advice and not tailored to your situation.